Prednisone Prescriptions Dropped—It’s Not the Long-Term Plan Anymore

I discovered something about prednisone prescriptions that shocked me—and if you’re on prednisone right now, you need to know what it means for you.

I’m going to share something with you that I discovered just recently, and honestly, even as a pharmacist who specializes in prednisone, it stopped me in my tracks.

Prednisone prescriptions in the United States have fallen by 42% since 2018.

Now, before you think, “Okay, so what?”—let me tell you why this matters. The number of people with asthma didn’t drop by 42%. Rheumatoid arthritis didn’t disappear. Crohn’s disease, ulcerative colitis, lupus, polymyalgia rheumatica—none of these conditions magically resolved. In fact, they’ve probably all increased.

So if the patients didn’t disappear, where did all the prednisone go? And if you’re still taking it—what does this dramatic shift mean for you?

Watch now!

2018: The Peak Year for Both National Prescriptions and My Personal Prednisone Crisis

I have to tell you, 2018 wasn’t just the peak year for prednisone prescriptions in America. It was also the peak of my own personal prednisone hell.

That year, I was taking 60 mg of prednisone daily after nearly bleeding to death from ITP, a rare autoimmune platelet disorder. I was trapped in what so many of you know: that horrible cycle of high doses, desperate taper attempts, and disease flare-ups that send you right back to the beginning. The medication was keeping me alive, but I was living with moon face, weight gain, insomnia so brutal I couldn’t nap even when I was exhausted, bone loss fears, vision changes, and mood swings that made me feel like a stranger in my own body.

At that time, prednisone was still treated as something patients just had to endure. The side effects were barely explained. The long-term risks? Almost never discussed. You took your pill, dealt with the consequences, and hoped for the best.

So when I looked at the data and saw that prednisone prescriptions dropped by more than 40% since that peak year, I knew it didn’t happen by accident. Something fundamental shifted in how medicine thinks about this drug.

And I needed to understand what—because if you’re still on prednisone, you need to understand it too.

Analyzing the Data: Three Theories, One Clear Pattern

Let me walk you through what I found.

Since 2018, prednisone prescriptions have fallen by more than 42%. But here’s what didn’t fall: the actual diseases. The conditions that prednisone treats are all still very much with us. The need for inflammation control didn’t just evaporate.

At first, I wondered if doctors were just switching to other steroids—maybe methylprednisolone or dexamethasone. So I dug into the data. Methylprednisolone and prednisolone stayed mostly flat. Dexamethasone had a brief spike during COVID (when it was the only medication proven to save lives in severe COVID cases), but then it dropped back down.

When I converted all of these steroids into prednisone-equivalent doses and looked at total steroid exposure across the United States, it had still declined by nearly 40%.

This wasn’t doctors swapping one steroid for another. This was medicine intentionally using less steroid overall.

Then I thought about COVID. Yes, the pandemic caused a temporary dip in many prescriptions—fewer doctor visits meant fewer diagnoses and fewer new prescriptions. But here’s what caught my attention: after COVID, many medications rebounded. Antibiotics came back up. Blood pressure medications recovered. But prednisone didn’t.

That told me the shift was already happening before the pandemic. COVID just made it more visible.

Behind the Scenes: What Prior Authorization Work Revealed About Changing Medical Practice

This realization didn’t come out of nowhere for me. Between 2015 and 2020, I worked as a prior authorization and appeals pharmacist. Most patients don’t even know this job exists—I worked behind the scenes, reading the chart notes and appeal letters that doctors submitted (sometimes 50+ pages long) when they were trying to get newer, more expensive treatments approved for their patients.

And almost every single time, there was one thing doctors emphasized: How many times the patient had already been on prednisone. How many bursts? What was the taper history? How many cumulative months?

That prednisone history mattered. It was the evidence doctors used to prove that the old strategy wasn’t working—and that the risks were stacking up.

These weren’t theoretical risks from a pharmacy textbook. They were documented, measured harm: bone loss, diabetes, fractures, infections, mood disruptions, vision problems, sleep destruction.

So here’s what I think really changed: Medicine started taking its own documentation seriously.

There was no big announcement. No press conference saying, “We’re going to use less prednisone now.” Instead, multiple medical specialties—working independently—came to the same conclusion: Long-term prednisone works to control inflammation, but the cumulative damage is often worse than we admitted.

And I felt that damage myself. I lived it. Which is exactly why I’m so passionate about helping you understand what’s happening.

How Treatment Paradigms Shifted Across Major Medical Specialties

Let me show you what shifted, specialty by specialty, because this explains both the numbers and what it might mean for your treatment.

Respiratory Medicine: From Repeated Bursts to Targeted Biologics

Guidelines began explicitly warning against repeated oral steroid bursts. Instead, doctors were encouraged to use inhaled steroids (which deliver medication directly to the lungs with way less full-body exposure) and biologic medications like Xolair, Nucala, Fasenra, and Dupixent. These newer drugs target specific inflammatory pathways, so patients need fewer prednisone courses.

Gastroenterology: Redefining Prednisone as Rescue-Only Therapy

This is where the change was most dramatic. Prednisone used to be the backbone of Crohn’s and ulcerative colitis treatment. Now? It’s considered short-term rescue therapy only. Long-term maintenance moved to biologics like Remicade, Humira, Stelara, and Entyvio.

The treatment goal literally changed from “controlled with steroids” to “steroid-free remission.”

Rheumatology: Treat-to-Target Without Chronic Steroids

Rheumatologists adopted a “treat to target” approach—meaning control the disease without chronic prednisone when possible. For giant cell arteritis, drugs like Actemra were approved specifically to reduce steroid exposure. For polymyalgia rheumatica, newer options like Kevzara emerged for patients who couldn’t taper off.

Ten years ago, many of these options simply didn’t exist.

Dermatology: Moving Beyond the Burst-and-Taper Cycle

Conditions once managed with repeated prednisone bursts increasingly moved to targeted therapies like Dupixent.

Across every specialty, the message became the same: Prednisone still works. But it shouldn’t be the long-term plan if there’s any other option.

The Nutrient Depletion Factor That’s Rarely Discussed in Clinical Settings

Now, before I go any further, I need to pause and talk directly to you if you’re on prednisone right now.

Even though modern medicine now agrees that long-term prednisone causes real harm, many patients are still taking it—sometimes for months or years while waiting for the next treatment option to kick in or become available.

That waiting period is real. And here’s what almost nobody talks about during that time: Prednisone doesn’t just cause side effects—it actively steals nutrients your body needs.

Calcium for your bones. Vitamin D. Magnesium. Chromium for blood sugar and metabolism. Potassium. B vitamins.

When I was on 60 mg of prednisone, no one—not one person—warned me about that. No one told me my body was burning through these nutrients faster than I could replace them through food alone.

So after I finally got off prednisone and started rebuilding my health, I created Nutranize Zone.

It’s the supplement I designed specifically to replenish what prednisone steals. This doesn’t replace your treatment or cure disease—and it isn’t magic.

But if you’re on prednisone right now—especially if you’re in that waiting period between treatments—Nutranize is what I desperately wish I’d had: support for your bones, your metabolism, your sleep, and your body while you work with your doctor on the next steps.

I’ll link to it at the end if you want to learn more. But let me get back to what this prescribing shift means for you.

From Destination Drug to Bridge Therapy: Understanding Prednisone’s Redefined Role

Here’s the key takeaway, and I need you to really hear this: Prednisone didn’t disappear. Its role changed.

It used to be the destination—the medication you’d take indefinitely to control your disease. Now, it’s meant to be the bridge. It stabilizes acute inflammation quickly while other treatments are started, then you taper as those alternatives take effect. Or you stay at the lowest effective dose with the support of other therapies.

This shift explains the statistics: fewer prescriptions, shorter durations, more intentional use.

And here’s what this means if you’re on prednisone right now and struggling to get off it: That’s not you failing. That’s information.

Information that tells your doctor,

“We may need a different approach. We may need to explore other options. This isn’t working the way we hoped.”

The Communication Gap: When Guidelines Change But Patient Explanations Don’t

Here’s the problem I see over and over again: Guidelines changed. Prescribing patterns in many offices changed. But the explanation often didn’t.

So patients are left thinking, “Medicine uses less prednisone now. Why am I still on it? What’s wrong with me?”

Let me be crystal clear: Nothing is wrong with you.

If you’re asking these questions, it doesn’t make you a difficult patient. It makes you informed. It makes you someone who’s paying attention and who deserves answers.

You have every right to ask your doctor:

• Why am I on prednisone specifically?
• Is this meant to be temporary or long-term?
• What’s our plan for reducing or stopping it?
• Are there alternatives we haven’t explored?
• What monitoring should we be doing for bones, eyes, blood sugar?

Those aren’t pushy questions. They’re not inappropriate. They’re fundamental to you being a partner in your own care.

And if no one has explained the plan to you clearly, that’s not your fault. That’s a gap in the system—and you have every right to ask for clarity.

Validating the Patient Experience: The Invisible Burden of Side Effects

I need you to hear something else: Prednisone is isolating.

The side effects are real, but they’re often invisible to other people. Mood changes that make you feel like you’re losing your mind. Bone loss you can’t see but know is happening. Weight shifts that make you avoid mirrors. Crushing fatigue that no amount of sleep touches. Insomnia that leaves you wired and exhausted at the same time. And underneath it all, that constant, gnawing fear: “What is this doing to me long-term?”

So many of you have told me you feel pressure to just be grateful. Grateful the medication is working for your disease. Grateful you’re alive. As if acknowledging how hard prednisone is somehow means you’re ungrateful or complaining.

But you’re not imagining the struggle. The 42% drop in prescriptions is proof—actual statistical proof—that medicine finally started listening to what patients have been saying for decades: Long-term prednisone is hard.

And it’s okay to say that out loud. It’s okay to name it. That doesn’t mean prednisone is wrong for you. It means you deserve to understand why you’re on it, for how long, and what the plan is moving forward.

Practical Resources for Patients Currently Taking Prednisone

If you want to understand more about what patients are never told about prednisone, I’ve created resources specifically to help:

My Free Prednisone Checklist walks you through the 7 biggest mistakes to avoid and the key daily steps to protect your sleep, weight, mood, bones, heart, and blood sugar. It’s evidence-based and translated into plain English—exactly what I wish someone had handed me in 2017.

My video “7+ Things to Avoid While Taking Prednisone” is my most popular video because it names the things that quietly make side effects worse—things I wish I’d known before I started.

And if you want to support your body while you’re on prednisone, Nutranize Zone is the supplement I created to replenish what the drug steals. You can learn more at Nutranize.com.

What This Means for Your Care Going Forward

Prednisone prescriptions fell 42% because medicine finally recognized the harm and found better options for many patients.

Those options might not be available for everyone yet. They might not be right for your specific situation. But they exist. And that’s new. And that’s genuinely good news.

If this article helped you, please share it. Share it with another patient who’s struggling. Share it with a family member who doesn’t understand what you’re going through. Heck, share it with your doctor if you think it might help start a conversation.

Because here’s what I know after nearly bleeding to death, surviving high-dose prednisone, and now dedicating my career to helping others through it:

You’re not alone. You’re not imagining this. And you deserve care that reflects where medicine is today, not where it was in 2018.

You deserve clear information. You deserve compassionate support. And you deserve to know that the questions you’re asking are the right ones to ask.

Keep fighting, Prednisone Warriors. I’m here with you.